Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahad Quhal

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
European Urology|August 22, 2022
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Constance Thibault, et al.
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
European Urology Focus|February 11, 2023
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Hadi Mostafaei, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Scandinavian Journal of Urology|February 10, 2022
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysisSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
European Urology|August 22, 2022
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysisTakafumi Yanagisawa, Pawel Rajwa, Constance Thibault, et al.
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
The Journal of Urology|January 21, 2022
<i>En Bloc</i> Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and HistopathologyTakafumi Yanagisawa, Keiichiro Mori, Reza Sari Motlagh, et al.
European Urology Focus|February 11, 2023
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Hadi Mostafaei, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Scandinavian Journal of Urology|February 10, 2022
Comparison of short-term and long-term neoadjuvant hormone therapy prior to radical prostatectomy: a systematic review and meta-analysisSatoshi Katayama, Keiichiro Mori, Benjamin Pradere, et al.
European Urology Focus|March 25, 2021
Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease RecurrenceEkaterina Laukhtina, Mohammad Abufaraj, Abdallah Al-Ani, et al.
Pageof 14